Talk:Tenofovir alafenamide

Controversy in TAF development
Something needs to be mentioned about TAFs controversial development stoppage by Gilead in 2004 and restart later. And the statements made around that time in 2004 being inconsistent to investors. Also there should be mention of the lawsuits from the AHF and California patients regarding TDF vs. TAF safety/development that occurred in 2016, 2017, and 2018.

Here is an LA times article that mentions some of the issues prompting the controversy. http://www.latimes.com/business/la-fi-gilead-20160529-snap-story.html — Preceding unsigned comment added by 45.26.205.106 (talk) 07:16, 3 June 2018 (UTC)